![Snehal Patel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 132 M $ al 30/06/2026
Snehal S.
Patel is currently Director, Chief Executive & Financial Officer at Greenwich LifeSciences, Inc. since 2016 and has been with the company since 2010.
Mr. Patel is also VP-Operations at Welspun Corp.
Ltd. Education includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The University of Chicago.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GREENWICH LIFESCIENCES, INC. 38,23 % | 29/07/2026 | 5.611.402 ( 38,23 % ) | 132 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Director Ejecutivo | 01/06/2016 |
| WELSPUN CORP LIMITED | Director de Operaciones | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Welspun Corp. Ltd.
 Welspun Corp. Ltd. Industrial MachineryProducer Manufacturing Manufactures steel pipes, coils and plates | Producer Manufacturing |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
 Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
